Authors: Williams, CD Harrison, CN Lister, TA Norton, AJ Blystad, AK Coiffier, B Taghipour, G Schmitz, N Goldstone, AH

Citation: Cd. Williams et al., High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: A case-matched study from the European bone marrow transplant registry, J CL ONCOL, 19(3), 2001, pp. 727-735

Authors: Blystad, AK Holte, H Kvaloy, S Smeland, E Delabie, J Kvalheim, G

Citation: Ak. Blystad et al., High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells, BONE MAR TR, 28(9), 2001, pp. 849-857

Authors: Blystad, AK Enblad, G Kvaloy, S Berglund, A Delabie, J Holte, H Carlson, K Kvalheim, G Bengtsson, M Hagberg, H

Citation: Ak. Blystad et al., High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas, BONE MAR TR, 27(7), 2001, pp. 711-716

Authors: Josefsen, D Blomhoff, HK Lomo, J Blystad, AK Smeland, EB

Citation: D. Josefsen et al., Retinoic acid induces apoptosis of human CD34(+) hematopoietic progenitor cells: Involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells, EXP HEMATOL, 27(4), 1999, pp. 642-653

Authors: Blystad, AK Kvalheim, G Torlakovic, E Holte, H Jacobsen, E Beiske, K Valerhaugen, H Lenschow, E Kvaloy, S

Citation: Ak. Blystad et al., High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma, BONE MAR TR, 24(8), 1999, pp. 865-872